Kao John E
KAO JOHN E, CEO, reported an open-market or private sale at Alignment Healthcare, Inc. involving 17107.000000 shares for an estimated $299971.25. Reported holdings after the transaction were 1508641.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- May 11, 2026
- Filing date
- May 13, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,525,748 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
ALHC price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001628280-26-034621 Common Stock
- Transaction date
- May 11, 2026 Filed May 13, 2026, 08:19 PM · 2d delay
- Shares
- 17,107 sh $17.54 per share
- Estimated value
- -$299k Computed from shares × price
- Holdings after
- 1,508,641 sh Indirect · See Footnote
Filing signal explanations
Badges describe filing facts only — not predictions.
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Executive Officer
- F1
Date of Rule 10b5-1 plan adoption: 11/21/2025
- F2
The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.22 to $17.16. The reporting person undertakes to provide to…
- F3
Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
- F4
The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.22 to $17.70. The reporting person undertakes to provide to…
0 other transactions
0 recent txs